Danaher Corp., US2358511028

Goldman Sachs adjusts target for Danaher Corp stock to USD 275.00

Published on 10/27/2026 at 16:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Revenue rose 8.50 percent in the third quarter. Danaher Corp stock costs EUR 208.50 on October 27, 2026, plus 0.48 percent versus Xetra close.

Analyst target and quarterly growth

  • Goldman Sachs set a USD 275.00 target on October 22, 2026, up from USD 250.00.
  • Danaher's third-quarter revenue rose 8.50 percent year over year to USD 6.60 billion.
  • Danaher stock costs EUR 208.50 at Lang & Schwarz on October 27, 2026 at 4:33 p.m. CEST, 0.48 percent above the Xetra close of October 26, 2026.
  • The stock's price-to-earnings ratio was 38.01 and its market capitalization was USD 163.4 billion on October 27, 2026.
Danaher Corp., US2358511028, Illustration mit AI erstellt.

Goldman Sachs adjusted its Danaher Corp target to USD 275.00 from USD 250.00 on October 22, 2026, according to MarketScreener. The revised target is 18.31 percent above the USD 232.43 Danaher price on the NYSE at 11:37 a.m. ET on October 27, 2026. Danaher stock was trading at EUR 208.50 at Lang & Schwarz on October 27, 2026 at 4:33 p.m. CEST, plus 0.48 percent versus the Xetra close of October 26, 2026 at EUR 207.50.

Third-quarter growth strengthens

Danaher reported third-quarter 2026 revenue of USD 6.60 billion, up 8.50 percent from the comparable quarter, in its release dated October 21, 2026. The same release showed net earnings of USD 1.20 billion, or USD 1.71 in GAAP diluted earnings per share, compared with USD 908.00 million and USD 1.27 in the prior-year quarter. The figures come from Danaher.

What does the target imply?

Goldman Sachs raised its target by USD 25.00, while the company guided to full-year 2026 adjusted diluted earnings per share of USD 8.57 to USD 8.62, versus prior guidance of USD 8.45 to USD 8.60. Danaher also expects fourth-quarter core revenue excluding respiratory revenue to grow between 4.00 percent and 5.00 percent, according to the October 21 release.

Price position and valuation

The NYSE quote of USD 232.43 stood between the USD 160.93 52-week low and USD 242.80 high on October 27, 2026. Danaher's market capitalization was USD 163.4 billion, its price-to-earnings ratio was 38.01 and trading volume was 711,526 shares. The euro quotation was EUR 208.50 at Lang & Schwarz at 4:33 p.m. CEST, against the dated Xetra close of EUR 207.50.

Comparison with peers

Danaher Corp.: plus 0.48 percent, price-to-earnings ratio 38.01, market capitalization USD 163.4 billion. Thermo Fisher Scientific (NYSE, USD): plus 1.47 percent, price-to-earnings ratio 36.63, market capitalization USD 257.0 billion. Agilent Technologies (NYSE, USD): plus 0.91 percent, price-to-earnings ratio 34.95, market capitalization USD 50.1 billion.

Investor perspective

The higher target and stronger third-quarter figures place attention on the conversion of revenue growth into adjusted earnings. The guidance range remains the next concrete benchmark for the company's valuation.

The further course of trading is shown by the continuously updated real-time quote of Danaher Corp stock.

Danaher Corp stock facts

  • Company: Danaher Corporation
  • ISIN: US2358511028
  • WKN: 866197
  • Ticker: DHR
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 27, 2026, 4:33 p.m. CEST): EUR 208.50
  • Change versus Xetra close: plus 0.48 percent
  • Xetra close (October 26, 2026): EUR 207.50
  • Market capitalization: USD 163.4 billion (as of October 27, 2026)
  • 52-week range: USD 160.93-242.80 (as of October 27, 2026)
  • Sector / Industry: Healthcare / Medical Diagnostics and Research

Market context: Market report S&P 500.

More news and analyses on Danaher Corp stock

Disclaimer...
en | US2358511028 | DANAHER CORP. | boerse | 70421547 |